Johnson & Johnson invested USD 2 billion in North Carolina as it plans to expand its U.S. manufacturing presence amid looming drug import duties proposed by President Donald Trump's administration. Prominent drugmakers, including Eli Lilly and AstraZeneca, have also planned to shell out billions of dollars to scale up their U.S. footprint. https://www.coherentmarketinsights.com/news/johnson-johnson-jnj-financial-invested-usd-2-billion-to-expand-its-us-manufacturing-technology-1384